Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.155 USD | +6.88% | +2.01% | -19.38% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.38% | 1.04B | |
+1.92% | 42.59B | |
+7.76% | 40.65B | |
+49.22% | 40.57B | |
-11.96% | 26.77B | |
+9.49% | 24.81B | |
-24.34% | 18.17B | |
+27.28% | 12.05B | |
-3.22% | 11.7B | |
+6.85% | 11.1B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir Biotechnology : , GlaxoSmithKline Halts Enrollment in Phase 3 Trial of Experimental COVID-19 Drug